Revasum Appoints Dr. Karey Holland Chief Technology Officer

SAN LUIS OBISPO, Calif., Sept. 13, 2021 /PRNewswire/ -- Global semiconductor technology and equipment firm Revasum, Inc. (ASX: RVS, 'Revasum' or 'the Company') is pleased to announce the appointment of Dr. Karey Holland to the role of Chief Technology Officer (CTO), effective immediately.  

Dr. Holland will oversee the research and development of the Company's silicon and silicon carbide wafer processing equipment and technology. She will lead the drive to increase Revasum's wafer grinding and polishing equipment offering while enhancing existing product capabilities.

For more than 30 years, Dr. Holland has led advances in chemical mechanical planarization (CMP) and photolithography and specialized in advanced semiconductor transistor fabrication, including metrology, etch, deposition and interconnect technologies.  Dr. Holland joins Revasum from Atlas Copco unit, Edwards Vacuum, where she was the Global Market Sector Manager for Semiconductor Process Technology. Before that she was VP, Process Technology at Mega Fluid Systems Inc, and has held senior and CTO roles with FEI, NexPlanar, Thomas West, and SpeedFam-IPEC. She is also a founding partner of advisory firm Techcet, LLC. She was a Board member of Nova Measuring Instruments. Dr. Holland joined the semiconductor industry at IBM.   She earned her Ph.D. in analytical chemistry from Pennsylvania State University, a M.S. in analytical chemistry from Purdue University, and a B.A. in chemistry from Albion College.

Revasum President and CEO Rebecca Shooter-Dodd said:

"We are delighted to welcome Dr. Karey Holland to the Revasum executive team. Her extensive experience will ensure that we continue to design and manufacture products that meet the global semiconductor industry's requirements, and remain a market leader in the development of silicon and silicon carbide single-wafer processing equipment.

"With industry-leading expertise and technical capabilities, our team is developing solutions for customers that are not available anywhere else in the world. We are pleased Dr. Holland has joined the Revasum team at this exciting time as we look to build out our product suite and boost production in line with our growth targets.

"I would also like to acknowledge and thank our Vice President of Engineering, Bill Kalenian, for his contribution as Acting CTO while we confirmed Dr. Holland's appointment."

Dr. Karey Holland said:

"Revasum's products are at the cutting edge of silicon carbide single-wafer processing technology in the world. The semiconductor sector is experiencing a time of rapid change and growth and I'm excited to join this collaborative and innovative team that is leading the way in technology advancement to increase the efficiency and quality of wafer processing."

THIS ANNOUNCEMENT WAS AUTHORIZED FOR RELEASE BY THE PRESIDENT AND CEO

Safe Harbor Statement

This announcement contains forward-looking statements, which address a variety of subjects including, for example, financial projections, our statements regarding expected events, including expected revenue and earnings, system shipments, expected product offerings, product development, market adoption and technical advances. Statements that are not historical facts, including statements about our beliefs, plans and expectations, are forward-looking statements. Such statements are based on our current expectations and information currently available to management and are subject to a number of factors and uncertainties, many of which are outside the control of the Company, which could cause actual results to differ materially from those described in the forward-looking statements. The Company's management believes that these forward-looking statements are reasonable as and when made. However, you should not place undue reliance on any such forward-looking statements because such statements speak only as of the date they are made. Revasum does not undertake any obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law or the ASX Listing Rules. In addition, forward-looking statements are subject to certain risks and uncertainties that could cause actual results, events and developments to differ materially from our historical experience and our present expectations or projections.

About Revasum

Revasum (ARBN: 629 268 533) specializes in the design and manufacturing of equipment used for the global semiconductor industry.  Revasum's equipment helps drive advanced manufacturing technology for critical growth markets, including automotive, IoT, and 5G. Our product portfolio includes state of the art equipment for the grinding, polishing, and chemical mechanical planarization processes used to manufacture devices for those key end markets. All of Revasum's equipment is designed and developed in close collaboration with our customers.  Learn how we create the equipment that generates the technology of today and tomorrow, visit www.revasum.com.

SOURCE Revasum, Inc.

Related Links

https://www.revasum.com